Foxo Technologies Inc. Announces Closing Of $10 Million Investment To Launch Foxo Life And Continue Commercializing Epigenetic Biomarker Technology
Foxo Technologies Inc. Announces Closing Of $10 Million Investment To Launch Foxo Life And Continue Commercializing Epigenetic Biomarker Technology
04/07/21, 7:55 PM
Location
minneapolisFOXO Technologies Inc. ("FOXO") today announced that it has closed a $10 million investment led by healthcare and technology investor Bespoke Growth Partners, Inc. The investment represents the first external capital FOXO has received and brings its total funding to $40 million.
Company Info
Company
Foxo
Location
minneapolis, minnesota, united states
Additional Info
FOXO Technologies Inc. uses AI-driven bioinformatics and microarray technologies to develop and commercialize epigenetic biomarkers of health and aging. FOXO provides insurers, health researchers, and life science companies with laboratory services, microarray design, and AI-driven bioinformatics software solutions for generating novel health-based insights into lifespan. For more information about FOXO, visit www.foxotechnologies.com or email [email protected].